Novel motif:42: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{Novel_motif
|name=motif42_CGNTCA
|novel_motifs_human_sample_pval=11376-118A8_11051;0.343823,11327-117E4_11969;0.121942,11473-119C6_11054;0.300218,11474-119C7_12067;0.64070...") |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 14:43, 9 September 2013
name: | motif42_CGNTCA |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0006481 | C-terminal protein methylation | 7.998625e-10 |
GO:0031929 | TOR signaling cascade | 8.343789e-8 |
GO:0051313 | attachment of spindle microtubules to chromosome | 9.489041e-8 |
GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development | 1.125278e-7 |
GO:0006369 | termination of RNA polymerase II transcription | 1.250812e-7 |
GO:0010836 | negative regulation of protein ADP-ribosylation | 3.119637e-7 |
GO:0042149 | cellular response to glucose starvation | 3.932530e-7 |
GO:0002863 | positive regulation of inflammatory response to antigenic stimulus | 8.014499e-7 |
GO:0000387 | spliceosomal snRNP assembly | 1.293966e-6 |
GO:0043503 | skeletal muscle fiber adaptation | 1.339861e-6 |
GO:0007021 | tubulin complex assembly | 1.610496e-6 |
GO:0072668 | tubulin complex biogenesis | 2.176417e-6 |
GO:0060017 | parathyroid gland development | 4.931050e-6 |
GO:0010625 | positive regulation of Schwann cell proliferation | 5.665798e-6 |
GO:0000296 | spermine transport | 5.683164e-6 |
GO:0031468 | nuclear envelope reassembly | 5.691087e-6 |
GO:0072268 | pattern specification involved in metanephros development | 6.680332e-6 |
GO:0006534 | cysteine metabolic process | 6.937638e-6 |
GO:0006364 | rRNA processing | 7.465565e-6 |
GO:0002769 | natural killer cell inhibitory signaling pathway | 7.997172e-6 |
GO:0032926 | negative regulation of activin receptor signaling pathway | 9.682684e-6 |
GO:0016072 | rRNA metabolic process | 9.824884e-6 |
GO:0043128 | positive regulation of 1-phosphatidylinositol 4-kinase activity | 1.242270e-5 |
GO:0006600 | creatine metabolic process | 1.851806e-5 |
GO:0002431 | Fc receptor mediated stimulatory signaling pathway | 1.897100e-5 |
GO:0001805 | positive regulation of type III hypersensitivity | 1.897100e-5 |
GO:0097029 | mature dendritic cell differentiation | 2.139660e-5 |
GO:0060977 | coronary vasculature morphogenesis | 2.162981e-5 |
GO:0042503 | tyrosine phosphorylation of Stat3 protein | 2.317316e-5 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 2.369773e-5 |
GO:0032769 | negative regulation of monooxygenase activity | 2.712241e-5 |
GO:0002861 | regulation of inflammatory response to antigenic stimulus | 3.138533e-5 |
GO:0002036 | regulation of L-glutamate transport | 3.206625e-5 |
GO:0044140 | negative regulation of growth of symbiont on or near host surface | 3.296437e-5 |
GO:0000414 | regulation of histone H3-K36 methylation | 3.792895e-5 |
GO:0010624 | regulation of Schwann cell proliferation | 3.890670e-5 |
GO:0061015 | snRNA import into nucleus | 3.982039e-5 |
GO:0006868 | glutamine transport | 5.059592e-5 |
GO:0046813 | virion attachment, binding of host cell surface receptor | 6.280461e-5 |
GO:0008054 | cyclin catabolic process | 6.860684e-5 |
GO:0071421 | manganese ion transmembrane transport | 7.165429e-5 |
GO:0000389 | nuclear mRNA 3'-splice site recognition | 7.165429e-5 |
GO:0006447 | regulation of translational initiation by iron | 7.546016e-5 |
GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway | 7.885125e-5 |
GO:0060058 | positive regulation of apoptosis involved in mammary gland involution | 8.280190e-5 |
GO:0009070 | serine family amino acid biosynthetic process | 9.009246e-5 |
GO:0043088 | regulation of Cdc42 GTPase activity | 9.011434e-5 |
GO:0042506 | tyrosine phosphorylation of Stat5 protein | 9.346772e-5 |
GO:0014829 | vascular smooth muscle contraction | 9.687208e-5 |
GO:0070544 | histone H3-K36 demethylation | 9.750702e-5 |
GO:0043587 | tongue morphogenesis | 1.017182e-4 |
GO:0003218 | cardiac left ventricle formation | 1.039717e-4 |
GO:0060695 | negative regulation of cholesterol transporter activity | 1.098996e-4 |
GO:0070194 | synaptonemal complex disassembly | 1.166189e-4 |
GO:0031662 | positive regulation of cyclin-dependent protein kinase activity involved in G2/M | 1.166189e-4 |
GO:0008608 | attachment of spindle microtubules to kinetochore | 1.210474e-4 |
GO:0019344 | cysteine biosynthetic process | 1.211706e-4 |
GO:0009069 | serine family amino acid metabolic process | 1.268907e-4 |
GO:0006432 | phenylalanyl-tRNA aminoacylation | 1.274827e-4 |
GO:0021658 | rhombomere 3 morphogenesis | 1.397101e-4 |
GO:0014740 | negative regulation of muscle hyperplasia | 1.542898e-4 |
GO:0014888 | striated muscle adaptation | 1.569407e-4 |
GO:0007422 | peripheral nervous system development | 1.584031e-4 |
GO:0001710 | mesodermal cell fate commitment | 1.598154e-4 |
GO:0051764 | actin crosslink formation | 1.653489e-4 |
GO:0060356 | leucine import | 1.774854e-4 |
GO:0030644 | cellular chloride ion homeostasis | 1.775892e-4 |
GO:0003329 | pancreatic PP cell fate commitment | 1.808802e-4 |
GO:0003326 | pancreatic A cell fate commitment | 1.808802e-4 |
GO:0070814 | hydrogen sulfide biosynthetic process | 1.935285e-4 |
GO:0031619 | homologous chromosome orientation involved in meiotic metaphase I plate congression | 1.953373e-4 |
GO:0016340 | calcium-dependent cell-matrix adhesion | 2.040726e-4 |
GO:0000398 | nuclear mRNA splicing, via spliceosome | 2.088568e-4 |
GO:0048280 | vesicle fusion with Golgi apparatus | 2.097897e-4 |
GO:0002866 | positive regulation of acute inflammatory response to antigenic stimulus | 2.258101e-4 |
GO:0000083 | regulation of transcription involved in G1/S phase of mitotic cell cycle | 2.296836e-4 |
GO:0021895 | cerebral cortex neuron differentiation | 2.416787e-4 |
GO:0072179 | nephric duct formation | 2.452633e-4 |
GO:0043501 | skeletal muscle adaptation | 2.458098e-4 |
GO:0043491 | protein kinase B signaling cascade | 2.576128e-4 |
GO:0033342 | negative regulation of collagen binding | 2.622091e-4 |
GO:0010999 | regulation of eIF2 alpha phosphorylation by heme | 2.622091e-4 |
GO:0009589 | detection of UV | 2.622091e-4 |
GO:0003148 | outflow tract septum morphogenesis | 2.667608e-4 |
GO:0008380 | RNA splicing | 2.689319e-4 |
GO:0040040 | thermosensory behavior | 2.722947e-4 |
GO:0021530 | spinal cord oligodendrocyte cell fate specification | 2.722947e-4 |
GO:0051299 | centrosome separation | 3.084191e-4 |
GO:0050685 | positive regulation of mRNA processing | 3.125728e-4 |
GO:0022038 | corpus callosum development | 3.316074e-4 |
GO:0050667 | homocysteine metabolic process | 3.370696e-4 |
GO:0051457 | maintenance of protein location in nucleus | 3.713470e-4 |
GO:0072176 | nephric duct development | 3.737686e-4 |
GO:0060252 | positive regulation of glial cell proliferation | 3.913361e-4 |
GO:0072178 | nephric duct morphogenesis | 4.204488e-4 |
GO:0046796 | viral genome transport in host cell | 4.257581e-4 |
GO:0051205 | protein insertion into membrane | 4.466020e-4 |
GO:0051955 | regulation of amino acid transport | 4.551356e-4 |
GO:0003221 | right ventricular cardiac muscle tissue morphogenesis | 4.632164e-4 |
GO:0030277 | maintenance of gastrointestinal epithelium | 4.709759e-4 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 4.746038e-4 |
GO:0000375 | RNA splicing, via transesterification reactions | 4.852674e-4 |
GO:0001812 | positive regulation of type I hypersensitivity | 4.874073e-4 |
GO:0002885 | positive regulation of hypersensitivity | 4.882229e-4 |
GO:2000195 | negative regulation of female gonad development | 4.936341e-4 |
GO:0021892 | cerebral cortex GABAergic interneuron differentiation | 5.396603e-4 |
GO:0014002 | astrocyte development | 5.547211e-4 |
GO:0070141 | response to UV-A | 5.675822e-4 |
GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation | 5.743175e-4 |
GO:2000194 | regulation of female gonad development | 6.081873e-4 |
GO:0042254 | ribosome biogenesis | 6.168216e-4 |
GO:0035767 | endothelial cell chemotaxis | 6.208611e-4 |
GO:0043418 | homocysteine catabolic process | 6.379034e-4 |
GO:0061157 | mRNA destabilization | 6.379034e-4 |
GO:0019346 | transsulfuration | 6.379034e-4 |
GO:0010609 | posttranscriptional regulation of gene expression by mRNA localization | 6.379034e-4 |
GO:0006478 | peptidyl-tyrosine sulfation | 6.379034e-4 |
GO:0006535 | cysteine biosynthetic process from serine | 6.379034e-4 |
GO:0019343 | cysteine biosynthetic process via cystathionine | 6.379034e-4 |
GO:0034214 | protein hexamerization | 6.379504e-4 |
GO:2001037 | positive regulation of tongue muscle cell differentiation | 6.402081e-4 |
GO:0097152 | mesenchymal cell apoptosis | 6.402081e-4 |
GO:0060982 | coronary artery morphogenesis | 6.402081e-4 |
GO:0006844 | acyl carnitine transport | 6.618881e-4 |
GO:0008334 | histone mRNA metabolic process | 6.647063e-4 |
GO:0060620 | regulation of cholesterol import | 6.826938e-4 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 7.617982e-4 |
GO:0021869 | forebrain ventricular zone progenitor cell division | 7.709481e-4 |
GO:0002037 | negative regulation of L-glutamate transport | 7.724054e-4 |
GO:0045994 | positive regulation of translational initiation by iron | 7.724054e-4 |
GO:0021954 | central nervous system neuron development | 7.747934e-4 |
GO:0000415 | negative regulation of histone H3-K36 methylation | 8.474882e-4 |
GO:0048203 | vesicle targeting, trans-Golgi to endosome | 8.560100e-4 |
GO:0031023 | microtubule organizing center organization | 9.016996e-4 |
GO:0030579 | ubiquitin-dependent SMAD protein catabolic process | 9.089352e-4 |
GO:0007198 | inhibition of adenylate cyclase activity by serotonin receptor signaling pathway | 9.398048e-4 |
GO:0015761 | mannose transport | 9.398048e-4 |
GO:0006425 | glutaminyl-tRNA aminoacylation | 9.398048e-4 |
GO:0060534 | trachea cartilage development | 9.474918e-4 |
GO:0042508 | tyrosine phosphorylation of Stat1 protein | 9.688493e-4 |
GO:0070574 | cadmium ion transmembrane transport | 9.707680e-4 |
GO:0022613 | ribonucleoprotein complex biogenesis | 9.769768e-4 |
GO:0021528 | commissural neuron differentiation in spinal cord | 9.885217e-4 |
GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development | 9.885217e-4 |
GO:0003061 | positive regulation of the force of heart contraction by norepinephrine | 9.885217e-4 |
GO:0051956 | negative regulation of amino acid transport | 1.034135e-3 |
GO:0046500 | S-adenosylmethionine metabolic process | 1.046085e-3 |
GO:0035883 | enteroendocrine cell differentiation | 1.075395e-3 |
GO:0048790 | maintenance of presynaptic active zone structure | 1.091874e-3 |
GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane | 1.091874e-3 |
GO:0006379 | mRNA cleavage | 1.112634e-3 |
GO:0019264 | glycine biosynthetic process from serine | 1.113347e-3 |
GO:0000917 | barrier septum formation | 1.140343e-3 |
GO:0060020 | Bergmann glial cell differentiation | 1.175422e-3 |
GO:0051572 | negative regulation of histone H3-K4 methylation | 1.207469e-3 |
GO:0006626 | protein targeting to mitochondrion | 1.210529e-3 |
GO:0014738 | regulation of muscle hyperplasia | 1.214318e-3 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 1.271767e-3 |
GO:0006635 | fatty acid beta-oxidation | 1.274011e-3 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 1.279696e-3 |
GO:0006853 | carnitine shuttle | 1.281065e-3 |
GO:0006984 | ER-nucleus signaling pathway | 1.288719e-3 |
GO:0034660 | ncRNA metabolic process | 1.341469e-3 |
GO:0002864 | regulation of acute inflammatory response to antigenic stimulus | 1.368210e-3 |
GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus | 1.374723e-3 |
GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator | 1.379028e-3 |
GO:0006545 | glycine biosynthetic process | 1.417112e-3 |
GO:0043089 | positive regulation of Cdc42 GTPase activity | 1.446109e-3 |
GO:0022007 | convergent extension involved in neural plate elongation | 1.476350e-3 |
GO:0006423 | cysteinyl-tRNA aminoacylation | 1.506608e-3 |
GO:0014037 | Schwann cell differentiation | 1.577073e-3 |
GO:0006656 | phosphatidylcholine biosynthetic process | 1.609438e-3 |
GO:0072655 | establishment of protein localization in mitochondrion | 1.611345e-3 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 1.655448e-3 |
GO:0001798 | positive regulation of type IIa hypersensitivity | 1.679172e-3 |
GO:0006657 | CDP-choline pathway | 1.679707e-3 |
GO:0070407 | oxidation-dependent protein catabolic process | 1.683261e-3 |
GO:0061050 | regulation of cell growth involved in cardiac muscle cell development | 1.724978e-3 |
GO:0051297 | centrosome organization | 1.735828e-3 |
GO:0032526 | response to retinoic acid | 1.738568e-3 |
GO:0000380 | alternative nuclear mRNA splicing, via spliceosome | 1.757603e-3 |
GO:0051354 | negative regulation of oxidoreductase activity | 1.896291e-3 |
GO:0035305 | negative regulation of dephosphorylation | 1.990619e-3 |
GO:0061101 | neuroendocrine cell differentiation | 2.005748e-3 |
GO:0000185 | activation of MAPKKK activity | 2.017923e-3 |
GO:0016598 | protein arginylation | 2.040998e-3 |
GO:0035966 | response to topologically incorrect protein | 2.048233e-3 |
GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation | 2.220741e-3 |
GO:0070585 | protein localization in mitochondrion | 2.230471e-3 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 2.246759e-3 |
GO:0045007 | depurination | 2.258033e-3 |
GO:0032365 | intracellular lipid transport | 2.259824e-3 |
GO:0060659 | nipple sheath formation | 2.260973e-3 |
GO:0060649 | mammary gland bud elongation | 2.260973e-3 |
GO:0032211 | negative regulation of telomere maintenance via telomerase | 2.265487e-3 |
GO:0071318 | cellular response to ATP | 2.316361e-3 |
GO:0060621 | negative regulation of cholesterol import | 2.332510e-3 |
GO:0006398 | histone mRNA 3'-end processing | 2.332510e-3 |
GO:0007141 | male meiosis I | 2.452921e-3 |
GO:0045835 | negative regulation of meiosis | 2.452921e-3 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 2.492747e-3 |
GO:0034384 | high-density lipoprotein particle clearance | 2.531108e-3 |
GO:0019448 | L-cysteine catabolic process | 2.658220e-3 |
GO:0050689 | negative regulation of defense response to virus by host | 2.658220e-3 |
GO:0035104 | positive regulation of transcription via sterol regulatory element binding | 2.670222e-3 |
GO:0090083 | regulation of inclusion body assembly | 2.731066e-3 |
GO:0000089 | mitotic metaphase | 2.731066e-3 |
GO:0006285 | base-excision repair, AP site formation | 2.756802e-3 |
GO:0051793 | medium-chain fatty acid catabolic process | 2.800974e-3 |
GO:0042780 | tRNA 3'-end processing | 2.800974e-3 |
GO:0023035 | CD40 signaling pathway | 2.800974e-3 |
GO:0019062 | virion attachment to host cell surface receptor | 2.833530e-3 |
GO:0014745 | negative regulation of muscle adaptation | 2.834897e-3 |
GO:0046939 | nucleotide phosphorylation | 3.002666e-3 |
GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport | 3.069730e-3 |
GO:0021985 | neurohypophysis development | 3.069730e-3 |
GO:0019478 | D-amino acid catabolic process | 3.070815e-3 |
GO:0002438 | acute inflammatory response to antigenic stimulus | 3.070815e-3 |
GO:0032202 | telomere assembly | 3.188533e-3 |
GO:0090086 | negative regulation of protein deubiquitination | 3.286184e-3 |
GO:0001958 | endochondral ossification | 3.342188e-3 |
GO:0006760 | folic acid-containing compound metabolic process | 3.347199e-3 |
GO:0032099 | negative regulation of appetite | 3.356602e-3 |
GO:0016197 | endosome transport | 3.383108e-3 |
GO:0071843 | cellular component biogenesis at cellular level | 3.387245e-3 |
GO:0021666 | rhombomere 5 formation | 3.444092e-3 |
GO:0021660 | rhombomere 3 formation | 3.444092e-3 |
GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling | 3.447916e-3 |
GO:0046655 | folic acid metabolic process | 3.479070e-3 |
GO:0051001 | negative regulation of nitric-oxide synthase activity | 3.498523e-3 |
GO:0030073 | insulin secretion | 3.538190e-3 |
GO:0060976 | coronary vasculature development | 3.631848e-3 |
GO:0006457 | protein folding | 3.634346e-3 |
GO:0071584 | negative regulation of zinc ion import | 3.674908e-3 |
GO:0090281 | negative regulation of calcium ion import | 3.674908e-3 |
GO:0051791 | medium-chain fatty acid metabolic process | 3.674908e-3 |
GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process | 3.674908e-3 |
GO:0032915 | positive regulation of transforming growth factor beta2 production | 3.674908e-3 |
GO:0000073 | spindle pole body separation | 3.674908e-3 |
GO:0000072 | M phase specific microtubule process | 3.686237e-3 |
GO:0002149 | hypochlorous acid biosynthetic process | 3.706853e-3 |
GO:0032096 | negative regulation of response to food | 3.757154e-3 |
GO:0042558 | pteridine-containing compound metabolic process | 3.758066e-3 |
GO:0034470 | ncRNA processing | 3.777042e-3 |
GO:0046856 | phosphatidylinositol dephosphorylation | 3.809457e-3 |
GO:0002679 | respiratory burst involved in defense response | 3.850741e-3 |
GO:0000236 | mitotic prometaphase | 3.877185e-3 |
GO:0043951 | negative regulation of cAMP-mediated signaling | 3.959093e-3 |
GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity | 3.966046e-3 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 4.009327e-3 |
GO:0061084 | negative regulation of protein refolding | 4.012320e-3 |
GO:0001974 | blood vessel remodeling | 4.120758e-3 |
GO:0007260 | tyrosine phosphorylation of STAT protein | 4.121220e-3 |
GO:0019086 | late viral mRNA transcription | 4.165000e-3 |
GO:0034453 | microtubule anchoring | 4.198113e-3 |
GO:0051546 | keratinocyte migration | 4.315321e-3 |
GO:0051684 | maintenance of Golgi location | 4.404528e-3 |
GO:0045358 | negative regulation of interferon-beta biosynthetic process | 4.404528e-3 |
GO:0007029 | endoplasmic reticulum organization | 4.431562e-3 |
GO:0055025 | positive regulation of cardiac muscle tissue development | 4.433286e-3 |
GO:0007500 | mesodermal cell fate determination | 4.449302e-3 |
GO:2000667 | positive regulation of interleukin-13 secretion | 4.565187e-3 |
GO:2000665 | regulation of interleukin-13 secretion | 4.565187e-3 |
GO:2000703 | negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation | 4.565187e-3 |
GO:2000734 | negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation | 4.565187e-3 |
GO:2000664 | positive regulation of interleukin-5 secretion | 4.565187e-3 |
GO:2000607 | negative regulation of cell proliferation involved in mesonephros development | 4.565187e-3 |
GO:2000662 | regulation of interleukin-5 secretion | 4.565187e-3 |
GO:0071276 | cellular response to cadmium ion | 4.566371e-3 |
GO:0035441 | cell migration involved in vasculogenesis | 4.607649e-3 |
GO:0070171 | negative regulation of tooth mineralization | 4.656821e-3 |
GO:0033088 | negative regulation of immature T cell proliferation in thymus | 4.656821e-3 |
GO:0061103 | carotid body glomus cell differentiation | 4.657798e-3 |
GO:0061104 | adrenal chromaffin cell differentiation | 4.657798e-3 |
GO:0071259 | cellular response to magnetism | 4.657798e-3 |
GO:0061102 | stomach neuroendocrine cell differentiation | 4.657798e-3 |
GO:0003359 | noradrenergic neuron fate commitment | 4.657798e-3 |
GO:0061100 | lung neuroendocrine cell differentiation | 4.657798e-3 |
GO:0060163 | subpallium neuron fate commitment | 4.657798e-3 |
GO:0007400 | neuroblast fate determination | 4.657798e-3 |
GO:0060165 | regulation of timing of subpallium neuron differentiation | 4.657798e-3 |
GO:0021592 | fourth ventricle development | 4.716736e-3 |
GO:0072595 | maintenance of protein localization to organelle | 4.778372e-3 |
GO:0006839 | mitochondrial transport | 4.829065e-3 |
GO:0034505 | tooth mineralization | 5.086353e-3 |
GO:0007000 | nucleolus organization | 5.184415e-3 |
GO:0046778 | modification by virus of host mRNA processing | 5.184415e-3 |
GO:0051642 | centrosome localization | 5.209748e-3 |
GO:0006986 | response to unfolded protein | 5.278498e-3 |
GO:0002883 | regulation of hypersensitivity | 5.388822e-3 |
GO:0034380 | high-density lipoprotein particle assembly | 5.388822e-3 |
GO:0018208 | peptidyl-proline modification | 5.404925e-3 |
GO:0051953 | negative regulation of amine transport | 5.448279e-3 |
GO:0006348 | chromatin silencing at telomere | 5.491869e-3 |
GO:0002765 | immune response-inhibiting signal transduction | 5.491869e-3 |
GO:0048050 | post-embryonic eye morphogenesis | 5.703485e-3 |
GO:0002502 | peptide antigen assembly with MHC class I protein complex | 5.703485e-3 |
GO:0061004 | pattern specification involved in kidney development | 5.755416e-3 |
GO:0090085 | regulation of protein deubiquitination | 5.792708e-3 |
GO:0001732 | formation of translation initiation complex | 5.937668e-3 |
GO:0090035 | positive regulation of cellular chaperone-mediated protein complex assembly | 5.964558e-3 |
GO:0060350 | endochondral bone morphogenesis | 5.973655e-3 |
GO:0051668 | localization within membrane | 5.989617e-3 |
GO:0015696 | ammonium transport | 6.029719e-3 |
GO:0032374 | regulation of cholesterol transport | 6.036504e-3 |
GO:0051929 | positive regulation of calcium ion transport via voltage-gated calcium channel activity | 6.113618e-3 |
GO:0006396 | RNA processing | 6.208340e-3 |
GO:0006366 | transcription from RNA polymerase II promoter | 6.220323e-3 |
GO:0046466 | membrane lipid catabolic process | 6.264456e-3 |
GO:0001574 | ganglioside biosynthetic process | 6.331945e-3 |
GO:0032812 | positive regulation of epinephrine secretion | 6.366116e-3 |
GO:0070253 | somatostatin secretion | 6.366116e-3 |
GO:0034162 | toll-like receptor 9 signaling pathway | 6.366116e-3 |
GO:2001054 | negative regulation of mesenchymal cell apoptosis | 6.446211e-3 |
GO:0009258 | 10-formyltetrahydrofolate catabolic process | 6.446211e-3 |
GO:0051177 | meiotic sister chromatid cohesion | 6.446211e-3 |
GO:0044070 | regulation of anion transport | 6.506764e-3 |
GO:0065001 | specification of axis polarity | 6.523590e-3 |
GO:0003062 | regulation of heart rate by chemical signal | 6.523590e-3 |
GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development | 6.543954e-3 |
GO:0000090 | mitotic anaphase | 6.798372e-3 |
GO:0006563 | L-serine metabolic process | 6.920479e-3 |
GO:0032682 | negative regulation of chemokine production | 6.962619e-3 |
GO:0035284 | brain segmentation | 7.117438e-3 |
GO:0070076 | histone lysine demethylation | 7.159931e-3 |
GO:0048708 | astrocyte differentiation | 7.230459e-3 |
GO:0006670 | sphingosine metabolic process | 7.288507e-3 |
GO:0006544 | glycine metabolic process | 7.289142e-3 |
GO:0017183 | peptidyl-diphthamide biosynthetic process from peptidyl-histidine | 7.290690e-3 |
GO:0034446 | substrate adhesion-dependent cell spreading | 7.366679e-3 |
GO:0060535 | trachea cartilage morphogenesis | 7.471763e-3 |
GO:0030037 | actin filament reorganization involved in cell cycle | 7.522596e-3 |
GO:0071294 | cellular response to zinc ion | 7.540521e-3 |
GO:0006998 | nuclear envelope organization | 7.630514e-3 |
GO:0060291 | long-term synaptic potentiation | 7.809324e-3 |
GO:0003016 | respiratory system process | 7.814432e-3 |
GO:0043984 | histone H4-K16 acetylation | 7.824501e-3 |
GO:0044356 | clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine | 8.000452e-3 |
GO:0010835 | regulation of protein ADP-ribosylation | 8.000452e-3 |
GO:0010994 | free ubiquitin chain polymerization | 8.000452e-3 |
GO:0051580 | regulation of neurotransmitter uptake | 8.026627e-3 |
GO:0051322 | anaphase | 8.069361e-3 |
GO:0009152 | purine ribonucleotide biosynthetic process | 8.111964e-3 |
GO:0002891 | positive regulation of immunoglobulin mediated immune response | 8.120573e-3 |
GO:0060014 | granulosa cell differentiation | 8.170061e-3 |
GO:0048702 | embryonic neurocranium morphogenesis | 8.170061e-3 |
GO:0045987 | positive regulation of smooth muscle contraction | 8.171302e-3 |
GO:0070093 | negative regulation of glucagon secretion | 8.349785e-3 |
GO:0090245 | axis elongation involved in somitogenesis | 8.349785e-3 |
GO:0021874 | Wnt receptor signaling pathway involved in forebrain neuroblast division | 8.349785e-3 |
GO:0030262 | apoptotic nuclear change | 8.363996e-3 |
GO:0006556 | S-adenosylmethionine biosynthetic process | 8.501185e-3 |
GO:0006828 | manganese ion transport | 8.503691e-3 |
GO:0018202 | peptidyl-histidine modification | 8.589338e-3 |
GO:0006273 | lagging strand elongation | 8.730096e-3 |
GO:0032506 | cytokinetic process | 8.869386e-3 |
GO:0040001 | establishment of mitotic spindle localization | 9.030475e-3 |
GO:0090205 | positive regulation of cholesterol metabolic process | 9.117102e-3 |
GO:0001661 | conditioned taste aversion | 9.117102e-3 |
GO:0042273 | ribosomal large subunit biogenesis | 9.186208e-3 |
GO:0048002 | antigen processing and presentation of peptide antigen | 9.242605e-3 |
GO:0090280 | positive regulation of calcium ion import | 9.300207e-3 |
GO:0072086 | specification of loop of Henle identity | 9.300207e-3 |
GO:0051298 | centrosome duplication | 9.420967e-3 |
GO:0021979 | hypothalamus cell differentiation | 9.428541e-3 |
GO:2000251 | positive regulation of actin cytoskeleton reorganization | 9.449491e-3 |
GO:0021877 | forebrain neuron fate commitment | 9.451554e-3 |
GO:0021562 | vestibulocochlear nerve development | 9.502812e-3 |
GO:0046340 | diacylglycerol catabolic process | 9.502812e-3 |
GO:0021987 | cerebral cortex development | 9.596522e-3 |
GO:0060561 | apoptosis involved in morphogenesis | 9.675298e-3 |
GO:0072081 | specification of nephron tubule identity | 9.787782e-3 |
GO:0034766 | negative regulation of ion transmembrane transport | 9.877264e-3 |
GO:0019402 | galactitol metabolic process | 9.899691e-3 |
GO:0006564 | L-serine biosynthetic process | 9.900781e-3 |
GO:0030149 | sphingolipid catabolic process | 1.019385e-2 |
GO:0010159 | specification of organ position | 1.024035e-2 |
GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway | 1.032360e-2 |
GO:0010669 | epithelial structure maintenance | 1.059912e-2 |
GO:0031064 | negative regulation of histone deacetylation | 1.091144e-2 |
GO:0006173 | dADP biosynthetic process | 1.094687e-2 |
GO:0021535 | cell migration in hindbrain | 1.107329e-2 |
GO:0045948 | positive regulation of translational initiation | 1.108956e-2 |
GO:0032012 | regulation of ARF protein signal transduction | 1.111909e-2 |
GO:0042255 | ribosome assembly | 1.114286e-2 |
GO:0014044 | Schwann cell development | 1.118579e-2 |
GO:0000413 | protein peptidyl-prolyl isomerization | 1.124692e-2 |
GO:0006550 | isoleucine catabolic process | 1.132964e-2 |
GO:0009098 | leucine biosynthetic process | 1.132964e-2 |
GO:0031860 | telomeric 3' overhang formation | 1.133397e-2 |
GO:0043456 | regulation of pentose-phosphate shunt | 1.133397e-2 |
GO:0009446 | putrescine biosynthetic process | 1.133397e-2 |
GO:0018872 | arsonoacetate metabolic process | 1.133397e-2 |
GO:0016056 | rhodopsin mediated signaling pathway | 1.144809e-2 |
GO:0051585 | negative regulation of dopamine uptake | 1.174581e-2 |
GO:0050812 | regulation of acyl-CoA biosynthetic process | 1.174581e-2 |
GO:0070495 | negative regulation of thrombin receptor signaling pathway | 1.174581e-2 |
GO:0051622 | negative regulation of norepinephrine uptake | 1.174581e-2 |
GO:0035881 | amacrine cell differentiation | 1.174581e-2 |
GO:0003108 | negative regulation of the force of heart contraction by chemical signal | 1.174581e-2 |
GO:0023021 | termination of signal transduction | 1.174581e-2 |
GO:0006353 | transcription termination, DNA-dependent | 1.184728e-2 |
GO:0060648 | mammary gland bud morphogenesis | 1.189591e-2 |
GO:2000143 | negative regulation of transcription initiation, DNA-dependent | 1.192647e-2 |
GO:0000416 | positive regulation of histone H3-K36 methylation | 1.192647e-2 |
GO:0009153 | purine deoxyribonucleotide biosynthetic process | 1.195039e-2 |
GO:0042776 | mitochondrial ATP synthesis coupled proton transport | 1.197629e-2 |
GO:0043901 | negative regulation of multi-organism process | 1.198710e-2 |
GO:0071529 | cementum mineralization | 1.202607e-2 |
GO:0072610 | interleukin-12 secretion | 1.202607e-2 |
GO:0002074 | extraocular skeletal muscle development | 1.202607e-2 |
GO:0002408 | myeloid dendritic cell chemotaxis | 1.202607e-2 |
GO:0010390 | histone monoubiquitination | 1.210649e-2 |
GO:0070963 | positive regulation of neutrophil mediated killing of gram-negative bacterium | 1.218904e-2 |
GO:0072608 | interleukin-10 secretion | 1.218904e-2 |
GO:0090198 | negative regulation of chemokine secretion | 1.218904e-2 |
GO:0051660 | establishment of centrosome localization | 1.218904e-2 |
GO:0043311 | positive regulation of eosinophil degranulation | 1.218904e-2 |
GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway | 1.218904e-2 |
GO:0021540 | corpus callosum morphogenesis | 1.218904e-2 |
GO:0035926 | chemokine (C-C motif) ligand 2 secretion | 1.218904e-2 |
GO:0035646 | endosome to melanosome transport | 1.221968e-2 |
GO:0018184 | protein polyamination | 1.221968e-2 |
GO:0046359 | butyrate catabolic process | 1.221968e-2 |
GO:0016095 | polyprenol catabolic process | 1.221968e-2 |
GO:0006272 | leading strand elongation | 1.221968e-2 |
GO:0040032 | post-embryonic body morphogenesis | 1.225224e-2 |
GO:0016071 | mRNA metabolic process | 1.247226e-2 |
GO:0009789 | positive regulation of abscisic acid mediated signaling pathway | 1.303260e-2 |
GO:0010870 | positive regulation of receptor biosynthetic process | 1.326631e-2 |
GO:0046325 | negative regulation of glucose import | 1.332586e-2 |
GO:0071930 | negative regulation of transcription involved in G1/S phase of mitotic cell cycle | 1.372141e-2 |
GO:0001771 | immunological synapse formation | 1.377137e-2 |
GO:0006406 | mRNA export from nucleus | 1.386259e-2 |
GO:0021615 | glossopharyngeal nerve morphogenesis | 1.396715e-2 |
GO:0008654 | phospholipid biosynthetic process | 1.427704e-2 |
GO:0006309 | DNA fragmentation involved in apoptotic nuclear change | 1.463398e-2 |
GO:0051685 | maintenance of ER location | 1.464632e-2 |
GO:0030490 | maturation of SSU-rRNA | 1.465760e-2 |
GO:0072107 | positive regulation of ureteric bud formation | 1.474590e-2 |
GO:0032933 | SREBP-mediated signaling pathway | 1.484194e-2 |
GO:0032765 | positive regulation of mast cell cytokine production | 1.486051e-2 |
GO:0046165 | alcohol biosynthetic process | 1.505927e-2 |
GO:0060564 | negative regulation of mitotic anaphase-promoting complex activity | 1.514276e-2 |
GO:0033136 | serine phosphorylation of STAT3 protein | 1.514276e-2 |
GO:0019348 | dolichol metabolic process | 1.514276e-2 |
GO:0035518 | histone H2A monoubiquitination | 1.515016e-2 |
GO:0042696 | menarche | 1.525090e-2 |
GO:0046022 | positive regulation of transcription from RNA polymerase II promoter during mitosis | 1.534877e-2 |
GO:0061028 | establishment of endothelial barrier | 1.560168e-2 |
GO:0015886 | heme transport | 1.565976e-2 |
GO:0019987 | negative regulation of anti-apoptosis | 1.591720e-2 |
GO:0032008 | positive regulation of TOR signaling cascade | 1.599458e-2 |
GO:2000573 | positive regulation of DNA biosynthetic process | 1.613130e-2 |
GO:0000093 | mitotic telophase | 1.613130e-2 |
GO:0006270 | DNA-dependent DNA replication initiation | 1.627968e-2 |
GO:0006119 | oxidative phosphorylation | 1.635895e-2 |
GO:0090279 | regulation of calcium ion import | 1.665163e-2 |
GO:0046718 | entry of virus into host cell | 1.685009e-2 |
GO:0043628 | ncRNA 3'-end processing | 1.689688e-2 |
GO:0006172 | ADP biosynthetic process | 1.689688e-2 |
GO:0045906 | negative regulation of vasoconstriction | 1.709738e-2 |
GO:0050779 | RNA destabilization | 1.709738e-2 |
GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling | 1.720585e-2 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 1.722181e-2 |
GO:0048752 | semicircular canal morphogenesis | 1.722855e-2 |
GO:0051898 | negative regulation of protein kinase B signaling cascade | 1.757910e-2 |
GO:0010874 | regulation of cholesterol efflux | 1.757910e-2 |
GO:0031167 | rRNA methylation | 1.762439e-2 |
GO:0035967 | cellular response to topologically incorrect protein | 1.775087e-2 |
GO:0021569 | rhombomere 3 development | 1.781772e-2 |
GO:0001768 | establishment of T cell polarity | 1.784550e-2 |
GO:0016090 | prenol metabolic process | 1.788121e-2 |
GO:0033490 | cholesterol biosynthetic process via lathosterol | 1.789084e-2 |
GO:0070145 | mitochondrial asparaginyl-tRNA aminoacylation | 1.789084e-2 |
GO:0071279 | cellular response to cobalt ion | 1.789084e-2 |
GO:0042376 | phylloquinone catabolic process | 1.789084e-2 |
GO:0010637 | negative regulation of mitochondrial fusion | 1.789084e-2 |
GO:0017126 | nucleologenesis | 1.789084e-2 |
GO:0030150 | protein import into mitochondrial matrix | 1.789084e-2 |
GO:0033085 | negative regulation of T cell differentiation in thymus | 1.807913e-2 |
GO:0021678 | third ventricle development | 1.828487e-2 |
GO:0021795 | cerebral cortex cell migration | 1.852566e-2 |
GO:0070947 | neutrophil mediated killing of fungus | 1.853217e-2 |
GO:0051030 | snRNA transport | 1.853217e-2 |
GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning | 1.853217e-2 |
GO:0006189 | 'de novo' IMP biosynthetic process | 1.853217e-2 |
GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway | 1.853217e-2 |
GO:0032108 | negative regulation of response to nutrient levels | 1.854053e-2 |
GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway | 1.864082e-2 |
GO:0045342 | MHC class II biosynthetic process | 1.883861e-2 |
GO:0043091 | L-arginine import | 1.883861e-2 |
GO:0070839 | divalent metal ion export | 1.883861e-2 |
GO:0006876 | cellular cadmium ion homeostasis | 1.883861e-2 |
GO:0015707 | nitrite transport | 1.883861e-2 |
GO:0032632 | interleukin-3 production | 1.883861e-2 |
GO:0007098 | centrosome cycle | 1.884336e-2 |
GO:0001878 | response to yeast | 1.913769e-2 |
GO:0003310 | pancreatic A cell differentiation | 1.919349e-2 |
GO:0015684 | ferrous iron transport | 1.920194e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0046477 | glycosylceramide catabolic process | 1.695751e-14 |
GO:0019673 | GDP-mannose metabolic process | 1.138116e-10 |
GO:0035269 | protein O-linked mannosylation | 1.278721e-10 |
GO:0046479 | glycosphingolipid catabolic process | 1.407510e-10 |
GO:0019348 | dolichol metabolic process | 5.192265e-10 |
GO:0043653 | mitochondrial fragmentation involved in apoptosis | 5.192265e-10 |
GO:0006677 | glycosylceramide metabolic process | 7.357993e-10 |
GO:0030240 | skeletal muscle thin filament assembly | 2.013869e-9 |
GO:0090083 | regulation of inclusion body assembly | 2.856457e-9 |
GO:0019377 | glycolipid catabolic process | 1.159828e-8 |
GO:0006396 | RNA processing | 1.239272e-8 |
GO:0044248 | cellular catabolic process | 1.592039e-8 |
GO:0006680 | glucosylceramide catabolic process | 1.633663e-8 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 1.971821e-8 |
GO:0043503 | skeletal muscle fiber adaptation | 1.742659e-7 |
GO:0006013 | mannose metabolic process | 4.909894e-7 |
GO:0034641 | cellular nitrogen compound metabolic process | 5.588003e-7 |
GO:0006139 | nucleobase-containing compound metabolic process | 5.762381e-7 |
GO:0014866 | skeletal myofibril assembly | 5.950279e-7 |
GO:0002098 | tRNA wobble uridine modification | 8.599318e-7 |
GO:0016139 | glycoside catabolic process | 8.611878e-7 |
GO:0006493 | protein O-linked glycosylation | 1.030879e-6 |
GO:0061084 | negative regulation of protein refolding | 1.530904e-6 |
GO:0034227 | tRNA thio-modification | 1.695758e-6 |
GO:0016236 | macroautophagy | 3.780690e-6 |
GO:0006678 | glucosylceramide metabolic process | 3.828022e-6 |
GO:0016574 | histone ubiquitination | 4.283964e-6 |
GO:0016071 | mRNA metabolic process | 4.415892e-6 |
GO:0034660 | ncRNA metabolic process | 5.004308e-6 |
GO:0009056 | catabolic process | 5.361525e-6 |
GO:0035645 | enteric smooth muscle cell differentiation | 6.043014e-6 |
GO:0007497 | posterior midgut development | 6.043014e-6 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 6.280156e-6 |
GO:0032481 | positive regulation of type I interferon production | 6.590457e-6 |
GO:0009057 | macromolecule catabolic process | 7.803699e-6 |
GO:0032515 | negative regulation of phosphoprotein phosphatase activity | 9.832258e-6 |
GO:0015780 | nucleotide-sugar transport | 1.092907e-5 |
GO:0034655 | nucleobase-containing compound catabolic process | 1.203682e-5 |
GO:0008334 | histone mRNA metabolic process | 1.240983e-5 |
GO:0044270 | cellular nitrogen compound catabolic process | 1.304020e-5 |
GO:0015992 | proton transport | 1.326396e-5 |
GO:0033238 | regulation of cellular amine metabolic process | 1.566457e-5 |
GO:0021528 | commissural neuron differentiation in spinal cord | 1.765020e-5 |
GO:0006807 | nitrogen compound metabolic process | 1.773761e-5 |
GO:0046700 | heterocycle catabolic process | 1.864660e-5 |
GO:0003096 | renal sodium ion transport | 1.956480e-5 |
GO:0032782 | bile acid secretion | 1.956480e-5 |
GO:0051351 | positive regulation of ligase activity | 1.964096e-5 |
GO:0006818 | hydrogen transport | 2.006608e-5 |
GO:0045345 | positive regulation of MHC class I biosynthetic process | 2.011406e-5 |
GO:0009154 | purine ribonucleotide catabolic process | 2.045853e-5 |
GO:0006657 | CDP-choline pathway | 2.132558e-5 |
GO:0006195 | purine nucleotide catabolic process | 2.201368e-5 |
GO:0009144 | purine nucleoside triphosphate metabolic process | 2.201835e-5 |
GO:0006402 | mRNA catabolic process | 2.242483e-5 |
GO:0007051 | spindle organization | 2.286821e-5 |
GO:0072523 | purine-containing compound catabolic process | 2.429632e-5 |
GO:0009205 | purine ribonucleoside triphosphate metabolic process | 2.514878e-5 |
GO:0009141 | nucleoside triphosphate metabolic process | 2.550359e-5 |
GO:0034470 | ncRNA processing | 2.591815e-5 |
GO:0009166 | nucleotide catabolic process | 2.625697e-5 |
GO:0009259 | ribonucleotide metabolic process | 2.966292e-5 |
GO:0009199 | ribonucleoside triphosphate metabolic process | 2.966314e-5 |
GO:0009207 | purine ribonucleoside triphosphate catabolic process | 3.059803e-5 |
GO:0070534 | protein K63-linked ubiquitination | 3.154447e-5 |
GO:0010467 | gene expression | 3.499042e-5 |
GO:0009261 | ribonucleotide catabolic process | 3.597064e-5 |
GO:0021570 | rhombomere 4 development | 3.710982e-5 |
GO:0009143 | nucleoside triphosphate catabolic process | 3.720745e-5 |
GO:0070925 | organelle assembly | 3.987079e-5 |
GO:0006401 | RNA catabolic process | 4.050719e-5 |
GO:0032416 | negative regulation of sodium:hydrogen antiporter activity | 4.769388e-5 |
GO:0000045 | autophagic vacuole assembly | 5.180620e-5 |
GO:0009146 | purine nucleoside triphosphate catabolic process | 5.430065e-5 |
GO:0009150 | purine ribonucleotide metabolic process | 5.504216e-5 |
GO:0022613 | ribonucleoprotein complex biogenesis | 5.665536e-5 |
GO:0045343 | regulation of MHC class I biosynthetic process | 6.415774e-5 |
GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity | 6.540512e-5 |
GO:0032513 | negative regulation of protein phosphatase type 2B activity | 6.791871e-5 |
GO:0016226 | iron-sulfur cluster assembly | 6.939358e-5 |
GO:0071843 | cellular component biogenesis at cellular level | 7.514462e-5 |
GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway | 7.822543e-5 |
GO:0006625 | protein targeting to peroxisome | 8.274844e-5 |
GO:0032727 | positive regulation of interferon-alpha production | 8.810037e-5 |
GO:0006200 | ATP catabolic process | 8.906663e-5 |
GO:0051645 | Golgi localization | 9.210374e-5 |
GO:0060047 | heart contraction | 9.782122e-5 |
GO:0048484 | enteric nervous system development | 9.892487e-5 |
GO:0032479 | regulation of type I interferon production | 1.024457e-4 |
GO:0006163 | purine nucleotide metabolic process | 1.028834e-4 |
GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway | 1.064661e-4 |
GO:2000781 | positive regulation of double-strand break repair | 1.064661e-4 |
GO:0070430 | positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 1.093973e-4 |
GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 1.093973e-4 |
GO:0072643 | interferon-gamma secretion | 1.093973e-4 |
GO:0090198 | negative regulation of chemokine secretion | 1.093973e-4 |
GO:0072608 | interleukin-10 secretion | 1.093973e-4 |
GO:0070963 | positive regulation of neutrophil mediated killing of gram-negative bacterium | 1.093973e-4 |
GO:0032707 | negative regulation of interleukin-23 production | 1.093973e-4 |
GO:0050983 | deoxyhypusine biosynthetic process from spermidine, using deoxyhypusine synthase | 1.093973e-4 |
GO:0035926 | chemokine (C-C motif) ligand 2 secretion | 1.093973e-4 |
GO:0045362 | positive regulation of interleukin-1 biosynthetic process | 1.093973e-4 |
GO:0043311 | positive regulation of eosinophil degranulation | 1.093973e-4 |
GO:0090304 | nucleic acid metabolic process | 1.172489e-4 |
GO:0043316 | cytotoxic T cell degranulation | 1.226962e-4 |
GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway | 1.226962e-4 |
GO:0033522 | histone H2A ubiquitination | 1.259149e-4 |
GO:0030433 | ER-associated protein catabolic process | 1.453206e-4 |
GO:0007340 | acrosome reaction | 1.549454e-4 |
GO:0042743 | hydrogen peroxide metabolic process | 1.596647e-4 |
GO:0051488 | activation of anaphase-promoting complex activity | 1.619161e-4 |
GO:0046688 | response to copper ion | 1.627234e-4 |
GO:0060005 | vestibular reflex | 1.656983e-4 |
GO:0048025 | negative regulation of nuclear mRNA splicing, via spliceosome | 1.669674e-4 |
GO:0016072 | rRNA metabolic process | 1.776184e-4 |
GO:0060048 | cardiac muscle contraction | 1.958020e-4 |
GO:0090169 | regulation of spindle assembly | 2.019832e-4 |
GO:0090234 | regulation of kinetochore assembly | 2.019832e-4 |
GO:0043491 | protein kinase B signaling cascade | 2.062783e-4 |
GO:0085020 | protein K6-linked ubiquitination | 2.072011e-4 |
GO:0016567 | protein ubiquitination | 2.157674e-4 |
GO:0097029 | mature dendritic cell differentiation | 2.167470e-4 |
GO:0040040 | thermosensory behavior | 2.167470e-4 |
GO:0051775 | response to redox state | 2.167470e-4 |
GO:0009220 | pyrimidine ribonucleotide biosynthetic process | 2.223017e-4 |
GO:0061099 | negative regulation of protein tyrosine kinase activity | 2.307391e-4 |
GO:0090084 | negative regulation of inclusion body assembly | 2.592649e-4 |
GO:0090086 | negative regulation of protein deubiquitination | 2.675020e-4 |
GO:0010845 | positive regulation of reciprocal meiotic recombination | 2.736626e-4 |
GO:0033239 | negative regulation of cellular amine metabolic process | 2.874481e-4 |
GO:2000272 | negative regulation of receptor activity | 2.884826e-4 |
GO:0042384 | cilium assembly | 2.982301e-4 |
GO:0030149 | sphingolipid catabolic process | 3.021807e-4 |
GO:0046514 | ceramide catabolic process | 3.085306e-4 |
GO:0015991 | ATP hydrolysis coupled proton transport | 3.218808e-4 |
GO:0006664 | glycolipid metabolic process | 3.408963e-4 |
GO:0006397 | mRNA processing | 3.628114e-4 |
GO:0006914 | autophagy | 3.664562e-4 |
GO:0000379 | tRNA-type intron splice site recognition and cleavage | 3.671698e-4 |
GO:2000649 | regulation of sodium ion transmembrane transporter activity | 3.677389e-4 |
GO:0044265 | cellular macromolecule catabolic process | 3.677448e-4 |
GO:0007214 | gamma-aminobutyric acid signaling pathway | 3.683033e-4 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 3.828709e-4 |
GO:0045792 | negative regulation of cell size | 3.893389e-4 |
GO:0010390 | histone monoubiquitination | 4.286680e-4 |
GO:0032446 | protein modification by small protein conjugation | 4.343102e-4 |
GO:0008637 | apoptotic mitochondrial changes | 4.515810e-4 |
GO:0018243 | protein O-linked glycosylation via threonine | 4.576571e-4 |
GO:0018242 | protein O-linked glycosylation via serine | 4.576571e-4 |
GO:0045787 | positive regulation of cell cycle | 4.721487e-4 |
GO:0048246 | macrophage chemotaxis | 4.779925e-4 |
GO:0009620 | response to fungus | 4.810769e-4 |
GO:0043403 | skeletal muscle tissue regeneration | 5.011660e-4 |
GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity | 5.165622e-4 |
GO:0016070 | RNA metabolic process | 5.396146e-4 |
GO:0006220 | pyrimidine nucleotide metabolic process | 5.400135e-4 |
GO:0000147 | actin cortical patch assembly | 5.479878e-4 |
GO:0046034 | ATP metabolic process | 5.599528e-4 |
GO:2000688 | positive regulation of rubidium ion transmembrane transporter activity | 5.681330e-4 |
GO:2000682 | positive regulation of rubidium ion transport | 5.681330e-4 |
GO:0001682 | tRNA 5'-leader removal | 5.681330e-4 |
GO:0016078 | tRNA catabolic process | 5.681330e-4 |
GO:0035826 | rubidium ion transport | 5.681330e-4 |
GO:0008654 | phospholipid biosynthetic process | 5.950020e-4 |
GO:0060658 | nipple morphogenesis | 6.120852e-4 |
GO:0072521 | purine-containing compound metabolic process | 6.165394e-4 |
GO:0009218 | pyrimidine ribonucleotide metabolic process | 6.325160e-4 |
GO:0016090 | prenol metabolic process | 6.378260e-4 |
GO:0055072 | iron ion homeostasis | 6.666498e-4 |
GO:0051321 | meiotic cell cycle | 6.726122e-4 |
GO:0080164 | regulation of nitric oxide metabolic process | 6.780228e-4 |
GO:0006683 | galactosylceramide catabolic process | 6.780228e-4 |
GO:0003015 | heart process | 6.933237e-4 |
GO:0016558 | protein import into peroxisome matrix | 6.972353e-4 |
GO:0051443 | positive regulation of ubiquitin-protein ligase activity | 7.056857e-4 |
GO:0006412 | translation | 7.073553e-4 |
GO:0046364 | monosaccharide biosynthetic process | 7.144574e-4 |
GO:0006513 | protein monoubiquitination | 7.600051e-4 |
GO:0006213 | pyrimidine nucleoside metabolic process | 7.621156e-4 |
GO:0006364 | rRNA processing | 7.887970e-4 |
GO:0050746 | regulation of lipoprotein metabolic process | 7.973880e-4 |
GO:0010927 | cellular component assembly involved in morphogenesis | 8.021564e-4 |
GO:0043949 | regulation of cAMP-mediated signaling | 8.402495e-4 |
GO:0045764 | positive regulation of cellular amino acid metabolic process | 8.519462e-4 |
GO:0051340 | regulation of ligase activity | 8.664272e-4 |
GO:0046548 | retinal rod cell development | 8.843434e-4 |
GO:0000079 | regulation of cyclin-dependent protein kinase activity | 8.869110e-4 |
GO:0043555 | regulation of translation in response to stress | 9.171774e-4 |
GO:0070562 | regulation of vitamin D receptor signaling pathway | 9.343082e-4 |
GO:0051661 | maintenance of centrosome location | 9.502175e-4 |
GO:0033240 | positive regulation of cellular amine metabolic process | 9.744184e-4 |
GO:0008380 | RNA splicing | 9.945963e-4 |
GO:0009996 | negative regulation of cell fate specification | 1.035100e-3 |
GO:0009117 | nucleotide metabolic process | 1.044117e-3 |
GO:0044260 | cellular macromolecule metabolic process | 1.056880e-3 |
GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity | 1.058441e-3 |
GO:0022417 | protein maturation by protein folding | 1.058441e-3 |
GO:0018158 | protein oxidation | 1.058441e-3 |
GO:0010454 | negative regulation of cell fate commitment | 1.066061e-3 |
GO:0046131 | pyrimidine ribonucleoside metabolic process | 1.069334e-3 |
GO:0071044 | histone mRNA catabolic process | 1.118594e-3 |
GO:0015696 | ammonium transport | 1.118594e-3 |
GO:0060674 | placenta blood vessel development | 1.131913e-3 |
GO:0051549 | positive regulation of keratinocyte migration | 1.139185e-3 |
GO:0032728 | positive regulation of interferon-beta production | 1.155637e-3 |
GO:0045083 | negative regulation of interleukin-12 biosynthetic process | 1.173196e-3 |
GO:0001881 | receptor recycling | 1.173196e-3 |
GO:0055089 | fatty acid homeostasis | 1.182438e-3 |
GO:0000305 | response to oxygen radical | 1.259169e-3 |
GO:0006457 | protein folding | 1.362916e-3 |
GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching | 1.372017e-3 |
GO:0043484 | regulation of RNA splicing | 1.374503e-3 |
GO:0043558 | regulation of translational initiation in response to stress | 1.384713e-3 |
GO:0022403 | cell cycle phase | 1.497306e-3 |
GO:0007494 | midgut development | 1.498013e-3 |
GO:0032347 | regulation of aldosterone biosynthetic process | 1.524346e-3 |
GO:0050691 | regulation of defense response to virus by host | 1.528835e-3 |
GO:0034661 | ncRNA catabolic process | 1.543691e-3 |
GO:0016137 | glycoside metabolic process | 1.602226e-3 |
GO:0031274 | positive regulation of pseudopodium assembly | 1.606715e-3 |
GO:0044237 | cellular metabolic process | 1.623274e-3 |
GO:0000375 | RNA splicing, via transesterification reactions | 1.623323e-3 |
GO:0034587 | piRNA metabolic process | 1.684257e-3 |
GO:0045358 | negative regulation of interferon-beta biosynthetic process | 1.722300e-3 |
GO:0060381 | positive regulation of single-stranded telomeric DNA binding | 1.722300e-3 |
GO:0030328 | prenylcysteine catabolic process | 1.722300e-3 |
GO:0070627 | ferrous iron import | 1.731698e-3 |
GO:0015676 | vanadium ion transport | 1.731698e-3 |
GO:0015692 | lead ion transport | 1.731698e-3 |
GO:0019319 | hexose biosynthetic process | 1.787112e-3 |
GO:0000279 | M phase | 1.806966e-3 |
GO:0034442 | regulation of lipoprotein oxidation | 1.832476e-3 |
GO:0033119 | negative regulation of RNA splicing | 1.853272e-3 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 1.869515e-3 |
GO:0009129 | pyrimidine nucleoside monophosphate metabolic process | 1.911404e-3 |
GO:0002339 | B cell selection | 1.987091e-3 |
GO:0006398 | histone mRNA 3'-end processing | 1.998552e-3 |
GO:0006172 | ADP biosynthetic process | 1.998552e-3 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 2.005796e-3 |
GO:0002825 | regulation of T-helper 1 type immune response | 2.017999e-3 |
GO:0060668 | regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling | 2.050423e-3 |
GO:0000398 | nuclear mRNA splicing, via spliceosome | 2.063904e-3 |
GO:0019430 | removal of superoxide radicals | 2.075805e-3 |
GO:0000413 | protein peptidyl-prolyl isomerization | 2.076553e-3 |
GO:0045922 | negative regulation of fatty acid metabolic process | 2.077591e-3 |
GO:0032647 | regulation of interferon-alpha production | 2.121789e-3 |
GO:0001732 | formation of translation initiation complex | 2.125123e-3 |
GO:0046007 | negative regulation of activated T cell proliferation | 2.176139e-3 |
GO:0006259 | DNA metabolic process | 2.179478e-3 |
GO:0072527 | pyrimidine-containing compound metabolic process | 2.216606e-3 |
GO:0006222 | UMP biosynthetic process | 2.252097e-3 |
GO:0032349 | positive regulation of aldosterone biosynthetic process | 2.255022e-3 |
GO:0051004 | regulation of lipoprotein lipase activity | 2.362007e-3 |
GO:0000188 | inactivation of MAPK activity | 2.373100e-3 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 2.408503e-3 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 2.440815e-3 |
GO:0060534 | trachea cartilage development | 2.440815e-3 |
GO:0043526 | neuroprotection | 2.515038e-3 |
GO:0001756 | somitogenesis | 2.610581e-3 |
GO:0021569 | rhombomere 3 development | 2.613094e-3 |
GO:0051289 | protein homotetramerization | 2.774481e-3 |
GO:0006405 | RNA export from nucleus | 2.779396e-3 |
GO:0070914 | UV-damage excision repair | 2.810521e-3 |
GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change | 2.810521e-3 |
GO:0045414 | regulation of interleukin-8 biosynthetic process | 2.869672e-3 |
GO:0060017 | parathyroid gland development | 2.869672e-3 |
GO:0033120 | positive regulation of RNA splicing | 2.904013e-3 |
GO:0035426 | extracellular matrix-cell signaling | 2.906108e-3 |
GO:0030033 | microvillus assembly | 2.908602e-3 |
GO:0046466 | membrane lipid catabolic process | 2.945483e-3 |
GO:0070535 | histone H2A K63-linked ubiquitination | 2.952525e-3 |
GO:0016142 | O-glycoside catabolic process | 2.952525e-3 |
GO:0042443 | phenylethylamine metabolic process | 2.952525e-3 |
GO:0031272 | regulation of pseudopodium assembly | 2.978535e-3 |
GO:0035082 | axoneme assembly | 2.979010e-3 |
GO:0006004 | fucose metabolic process | 2.979010e-3 |
GO:0046434 | organophosphate catabolic process | 3.173893e-3 |
GO:0051225 | spindle assembly | 3.173990e-3 |
GO:0060716 | labyrinthine layer blood vessel development | 3.181471e-3 |
GO:0030163 | protein catabolic process | 3.194982e-3 |
GO:0009133 | nucleoside diphosphate biosynthetic process | 3.218562e-3 |
GO:0035307 | positive regulation of protein dephosphorylation | 3.277377e-3 |
GO:0014826 | vein smooth muscle contraction | 3.306745e-3 |
GO:0034224 | cellular response to zinc ion starvation | 3.385573e-3 |
GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway | 3.385573e-3 |
GO:0006043 | glucosamine catabolic process | 3.400044e-3 |
GO:0042069 | regulation of catecholamine metabolic process | 3.437265e-3 |
GO:0006221 | pyrimidine nucleotide biosynthetic process | 3.678082e-3 |
GO:0002230 | positive regulation of defense response to virus by host | 3.691388e-3 |
GO:0042304 | regulation of fatty acid biosynthetic process | 3.712601e-3 |
GO:0031669 | cellular response to nutrient levels | 3.726035e-3 |
GO:0035306 | positive regulation of dephosphorylation | 3.772726e-3 |
GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process | 3.812190e-3 |
GO:0006473 | protein acetylation | 3.824895e-3 |
GO:0016075 | rRNA catabolic process | 3.830062e-3 |
GO:0090085 | regulation of protein deubiquitination | 3.882911e-3 |
GO:2000043 | regulation of cardiac cell fate specification | 3.904201e-3 |
GO:0015986 | ATP synthesis coupled proton transport | 3.937813e-3 |
GO:0008634 | negative regulation of survival gene product expression | 3.941488e-3 |
GO:0002827 | positive regulation of T-helper 1 type immune response | 3.941488e-3 |
GO:0044090 | positive regulation of vacuole organization | 3.980851e-3 |
GO:0009234 | menaquinone biosynthetic process | 3.980851e-3 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 4.003882e-3 |
GO:0007140 | male meiosis | 4.124691e-3 |
GO:0033962 | cytoplasmic mRNA processing body assembly | 4.145165e-3 |
GO:0035852 | horizontal cell localization | 4.202061e-3 |
GO:0035849 | nephric duct elongation | 4.202061e-3 |
GO:0043048 | dolichyl monophosphate biosynthetic process | 4.202061e-3 |
GO:0071279 | cellular response to cobalt ion | 4.202061e-3 |
GO:0035847 | uterine epithelium development | 4.202061e-3 |
GO:0070370 | cellular heat acclimation | 4.202061e-3 |
GO:2000768 | positive regulation of nephron tubule epithelial cell differentiation | 4.202061e-3 |
GO:0035846 | oviduct epithelium development | 4.202061e-3 |
GO:0006348 | chromatin silencing at telomere | 4.202061e-3 |
GO:0010637 | negative regulation of mitochondrial fusion | 4.202061e-3 |
GO:0009794 | regulation of mitotic cell cycle, embryonic | 4.202061e-3 |
GO:0032802 | low-density lipoprotein particle receptor catabolic process | 4.202061e-3 |
GO:0014808 | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 4.202061e-3 |
GO:0030261 | chromosome condensation | 4.220308e-3 |
GO:0010155 | regulation of proton transport | 4.241471e-3 |
GO:0050832 | defense response to fungus | 4.329933e-3 |
GO:0046939 | nucleotide phosphorylation | 4.329933e-3 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 4.338261e-3 |
GO:0071034 | CUT catabolic process | 4.348639e-3 |
GO:0051382 | kinetochore assembly | 4.348639e-3 |
GO:0018298 | protein-chromophore linkage | 4.353238e-3 |
GO:0008033 | tRNA processing | 4.413922e-3 |
GO:0032677 | regulation of interleukin-8 production | 4.430309e-3 |
GO:0070936 | protein K48-linked ubiquitination | 4.432977e-3 |
GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling | 4.444394e-3 |
GO:0006749 | glutathione metabolic process | 4.580987e-3 |
GO:0060631 | regulation of meiosis I | 4.726705e-3 |
GO:0045357 | regulation of interferon-beta biosynthetic process | 4.726705e-3 |
GO:0032007 | negative regulation of TOR signaling cascade | 4.799979e-3 |
GO:0042660 | positive regulation of cell fate specification | 4.917218e-3 |
GO:0006413 | translational initiation | 4.961855e-3 |
GO:2000036 | regulation of stem cell maintenance | 5.101950e-3 |
GO:0006309 | DNA fragmentation involved in apoptotic nuclear change | 5.110710e-3 |
GO:0046165 | alcohol biosynthetic process | 5.152681e-3 |
GO:0034637 | cellular carbohydrate biosynthetic process | 5.152681e-3 |
GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 5.159823e-3 |
GO:0002175 | protein localization to paranode region of axon | 5.159823e-3 |
GO:0051572 | negative regulation of histone H3-K4 methylation | 5.189660e-3 |
GO:0060586 | multicellular organismal iron ion homeostasis | 5.248395e-3 |
GO:0042254 | ribosome biogenesis | 5.474145e-3 |
GO:0050668 | positive regulation of homocysteine metabolic process | 5.492972e-3 |
GO:0045963 | negative regulation of dopamine metabolic process | 5.492972e-3 |
GO:0034635 | glutathione transport | 5.492972e-3 |
GO:0016073 | snRNA metabolic process | 5.552807e-3 |
GO:0006264 | mitochondrial DNA replication | 5.569350e-3 |
GO:0001826 | inner cell mass cell differentiation | 5.569350e-3 |
GO:0034755 | iron ion transmembrane transport | 5.589224e-3 |
GO:0061136 | regulation of proteasomal protein catabolic process | 5.686325e-3 |
GO:0030307 | positive regulation of cell growth | 5.718551e-3 |
GO:0007126 | meiosis | 5.834697e-3 |
GO:0042053 | regulation of dopamine metabolic process | 5.919986e-3 |
GO:0072528 | pyrimidine-containing compound biosynthetic process | 6.106035e-3 |
GO:0071545 | inositol phosphate catabolic process | 6.214918e-3 |
GO:0000303 | response to superoxide | 6.233011e-3 |
GO:0001836 | release of cytochrome c from mitochondria | 6.302315e-3 |
GO:0006687 | glycosphingolipid metabolic process | 6.333840e-3 |
GO:0048255 | mRNA stabilization | 6.373176e-3 |
GO:0010950 | positive regulation of endopeptidase activity | 6.375814e-3 |
GO:0045217 | cell-cell junction maintenance | 6.382647e-3 |
GO:0033128 | negative regulation of histone phosphorylation | 6.459498e-3 |
GO:0010501 | RNA secondary structure unwinding | 6.459498e-3 |
GO:0021530 | spinal cord oligodendrocyte cell fate specification | 6.459498e-3 |
GO:2000058 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 6.466234e-3 |
GO:0006475 | internal protein amino acid acetylation | 6.691164e-3 |
GO:0046587 | positive regulation of calcium-dependent cell-cell adhesion | 6.733206e-3 |
GO:0051895 | negative regulation of focal adhesion assembly | 6.913102e-3 |
GO:2000277 | positive regulation of oxidative phosphorylation uncoupler activity | 6.935791e-3 |
GO:0090310 | negative regulation of methylation-dependent chromatin silencing | 6.935791e-3 |
GO:0016480 | negative regulation of transcription from RNA polymerase III promoter | 6.935791e-3 |
GO:0045046 | protein import into peroxisome membrane | 6.935791e-3 |
GO:0032094 | response to food | 6.939089e-3 |
GO:0007141 | male meiosis I | 6.944664e-3 |
GO:0043320 | natural killer cell degranulation | 6.966196e-3 |
GO:0018126 | protein hydroxylation | 7.066782e-3 |
GO:0007033 | vacuole organization | 7.308838e-3 |
GO:0045906 | negative regulation of vasoconstriction | 7.495963e-3 |
GO:0014043 | negative regulation of neuron maturation | 7.495963e-3 |
GO:0048384 | retinoic acid receptor signaling pathway | 7.689408e-3 |
GO:0045872 | positive regulation of rhodopsin gene expression | 7.721308e-3 |
GO:2000653 | regulation of genetic imprinting | 7.721308e-3 |
GO:0034276 | kynurenic acid biosynthetic process | 7.721308e-3 |
GO:0002534 | cytokine production involved in inflammatory response | 7.721308e-3 |
GO:0032298 | positive regulation of DNA-dependent DNA replication initiation | 7.721308e-3 |
GO:0002159 | desmosome assembly | 7.721308e-3 |
GO:0070885 | negative regulation of calcineurin-NFAT signaling pathway | 7.769143e-3 |
GO:0042264 | peptidyl-aspartic acid hydroxylation | 7.769143e-3 |
GO:0001892 | embryonic placenta development | 7.985949e-3 |
GO:0007031 | peroxisome organization | 8.054054e-3 |
GO:0048752 | semicircular canal morphogenesis | 8.057713e-3 |
GO:0006885 | regulation of pH | 8.188558e-3 |
GO:0006406 | mRNA export from nucleus | 8.383642e-3 |
GO:0042744 | hydrogen peroxide catabolic process | 8.414755e-3 |
GO:0051030 | snRNA transport | 8.418408e-3 |
GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process | 8.418408e-3 |
GO:0000492 | box C/D snoRNP assembly | 8.418408e-3 |
GO:0019509 | L-methionine salvage from methylthioadenosine | 8.418408e-3 |
GO:0009260 | ribonucleotide biosynthetic process | 8.447119e-3 |
GO:0035434 | copper ion transmembrane transport | 8.492344e-3 |
GO:0060535 | trachea cartilage morphogenesis | 8.492344e-3 |
GO:0046173 | polyol biosynthetic process | 8.504143e-3 |
GO:0060158 | activation of phospholipase C activity by dopamine receptor signaling pathway | 8.620491e-3 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 8.620491e-3 |
GO:0007176 | regulation of epidermal growth factor-activated receptor activity | 8.744570e-3 |
GO:0006612 | protein targeting to membrane | 8.942318e-3 |
GO:0071108 | protein K48-linked deubiquitination | 9.141777e-3 |
GO:0042350 | GDP-L-fucose biosynthetic process | 9.262483e-3 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 9.295490e-3 |
GO:0045416 | positive regulation of interleukin-8 biosynthetic process | 9.295490e-3 |
GO:0046039 | GTP metabolic process | 9.377886e-3 |
GO:0071267 | L-methionine salvage | 9.531592e-3 |
GO:0008156 | negative regulation of DNA replication | 9.718461e-3 |
GO:0019217 | regulation of fatty acid metabolic process | 1.030759e-2 |
GO:0018393 | internal peptidyl-lysine acetylation | 1.033947e-2 |
GO:0060319 | primitive erythrocyte differentiation | 1.037228e-2 |
GO:0046322 | negative regulation of fatty acid oxidation | 1.037228e-2 |
GO:0006879 | cellular iron ion homeostasis | 1.053358e-2 |
GO:0060709 | glycogen cell development involved in embryonic placenta development | 1.081251e-2 |
GO:0045626 | negative regulation of T-helper 1 cell differentiation | 1.081251e-2 |
GO:0034135 | regulation of toll-like receptor 2 signaling pathway | 1.081251e-2 |
GO:0002537 | nitric oxide production involved in inflammatory response | 1.081251e-2 |
GO:0035282 | segmentation | 1.083987e-2 |
GO:0006228 | UTP biosynthetic process | 1.084074e-2 |
GO:0006165 | nucleoside diphosphate phosphorylation | 1.084074e-2 |
GO:0046483 | heterocycle metabolic process | 1.085122e-2 |
GO:0060711 | labyrinthine layer development | 1.086547e-2 |
GO:0051438 | regulation of ubiquitin-protein ligase activity | 1.088698e-2 |
GO:0010520 | regulation of reciprocal meiotic recombination | 1.091990e-2 |
GO:0021612 | facial nerve structural organization | 1.091990e-2 |
GO:0001755 | neural crest cell migration | 1.113008e-2 |
GO:0032107 | regulation of response to nutrient levels | 1.123631e-2 |
GO:0006415 | translational termination | 1.141784e-2 |
GO:0008635 | activation of caspase activity by cytochrome c | 1.168043e-2 |
GO:0030277 | maintenance of gastrointestinal epithelium | 1.168726e-2 |
GO:0009132 | nucleoside diphosphate metabolic process | 1.172071e-2 |
GO:0010741 | negative regulation of intracellular protein kinase cascade | 1.182274e-2 |
GO:0009267 | cellular response to starvation | 1.189377e-2 |
GO:0006399 | tRNA metabolic process | 1.197195e-2 |
GO:0018394 | peptidyl-lysine acetylation | 1.226480e-2 |
GO:0071985 | multivesicular body sorting pathway | 1.234393e-2 |
GO:0046985 | positive regulation of hemoglobin biosynthetic process | 1.234393e-2 |
GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery | 1.234393e-2 |
GO:0043973 | histone H3-K4 acetylation | 1.234393e-2 |
GO:0060729 | intestinal epithelial structure maintenance | 1.234680e-2 |
GO:0060482 | lobar bronchus development | 1.252191e-2 |
GO:0045618 | positive regulation of keratinocyte differentiation | 1.252191e-2 |
GO:0070634 | transepithelial ammonium transport | 1.254835e-2 |
GO:0061113 | pancreas morphogenesis | 1.254835e-2 |
GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway | 1.275557e-2 |
GO:0014041 | regulation of neuron maturation | 1.278104e-2 |
GO:0046031 | ADP metabolic process | 1.278104e-2 |
GO:0060166 | olfactory pit development | 1.279711e-2 |
GO:0035444 | nickel ion transmembrane transport | 1.279711e-2 |
GO:0031999 | negative regulation of fatty acid beta-oxidation | 1.279711e-2 |
GO:0071956 | cellular component maintenance at cellular level | 1.283383e-2 |
GO:0030970 | retrograde protein transport, ER to cytosol | 1.287904e-2 |
GO:0001913 | T cell mediated cytotoxicity | 1.287904e-2 |
GO:0032006 | regulation of TOR signaling cascade | 1.290124e-2 |
GO:0010269 | response to selenium ion | 1.302629e-2 |
GO:0006352 | transcription initiation, DNA-dependent | 1.318956e-2 |
GO:0070979 | protein K11-linked ubiquitination | 1.322442e-2 |
GO:0032413 | negative regulation of ion transmembrane transporter activity | 1.323742e-2 |
GO:0044085 | cellular component biogenesis | 1.344053e-2 |
GO:0043309 | regulation of eosinophil degranulation | 1.348786e-2 |
GO:0097152 | mesenchymal cell apoptosis | 1.348786e-2 |
GO:0042137 | sequestering of neurotransmitter | 1.348786e-2 |
GO:0034633 | retinol transport | 1.348786e-2 |
GO:0009597 | detection of virus | 1.348786e-2 |
GO:0035674 | tricarboxylic acid transmembrane transport | 1.348786e-2 |
GO:0009145 | purine nucleoside triphosphate biosynthetic process | 1.365152e-2 |
GO:0023021 | termination of signal transduction | 1.366424e-2 |
GO:0007191 | activation of adenylate cyclase activity by dopamine receptor signaling pathway | 1.366424e-2 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 1.366424e-2 |
GO:0051647 | nucleus localization | 1.382344e-2 |
GO:0008629 | induction of apoptosis by intracellular signals | 1.405822e-2 |
GO:0016180 | snRNA processing | 1.416871e-2 |
GO:0045604 | regulation of epidermal cell differentiation | 1.444529e-2 |
GO:0042119 | neutrophil activation | 1.445468e-2 |
GO:0006516 | glycoprotein catabolic process | 1.448231e-2 |
GO:0030031 | cell projection assembly | 1.464150e-2 |
GO:0046683 | response to organophosphorus | 1.477418e-2 |
GO:0061015 | snRNA import into nucleus | 1.477418e-2 |
GO:0045769 | negative regulation of asymmetric cell division | 1.477418e-2 |
GO:0035502 | metanephric ureteric bud development | 1.477418e-2 |
GO:0061316 | canonical Wnt receptor signaling pathway involved in heart development | 1.480908e-2 |
GO:0046125 | pyrimidine deoxyribonucleoside metabolic process | 1.480908e-2 |
GO:0006436 | tryptophanyl-tRNA aminoacylation | 1.480908e-2 |
GO:0045047 | protein targeting to ER | 1.492056e-2 |
GO:0050665 | hydrogen peroxide biosynthetic process | 1.498467e-2 |
GO:0006183 | GTP biosynthetic process | 1.498467e-2 |
GO:0043407 | negative regulation of MAP kinase activity | 1.505626e-2 |
GO:0010887 | negative regulation of cholesterol storage | 1.506393e-2 |
GO:0042424 | catecholamine catabolic process | 1.535490e-2 |
GO:0002344 | B cell affinity maturation | 1.535490e-2 |
GO:0006828 | manganese ion transport | 1.552647e-2 |
GO:0022618 | ribonucleoprotein complex assembly | 1.565524e-2 |